...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Two big thank you’s

tada - Yes, they are the same shares. The only question is the Fair Market Value assigned to them for the transfer. In an audit of the TFSA actions, it is up to CRA to accept or not accept the value you assigned to it. They might very well be fine with it.

Share
New Message
Please login to post a reply